Literature DB >> 16843187

Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease.

Craig S Broberg1, Bridget E Bax, Darlington O Okonko, Michael W Rampling, Stephanie Bayne, Carl Harries, Simon J Davidson, Anselm Uebing, Arif Anis Khan, Swee Thein, J Simon R Gibbs, John Burman, Michael A Gatzoulis.   

Abstract

OBJECTIVES: This study sought to determine the relationship between blood viscosity and iron deficiency and their impact on symptoms and exercise function in adults with cyanotic congenital heart disease.
BACKGROUND: Iron deficiency is believed to raise whole blood viscosity in cyanotic congenital heart disease, although available data are inconsistent.
METHODS: Thirty-nine cyanotic adults were prospectively assessed for iron deficiency (transferrin saturation < or =5%), hyperviscosity symptoms, and exercise capacity. Same-day measurement of whole blood viscosity and hematocrit (Hct) adjusted viscosity (cells resuspended in autologous plasma to Hct of 45%) was performed at shear rates ranging from 0.277 s(-1) to 128.5 s(-1).
RESULTS: Viscosity did not differ between patients with iron deficiency (n = 14) and those without (n = 25). Whole blood viscosity correlated with Hct (r = 0.63, p < 0.001 at low shear and r = 0.84, p < 0.001 at high shear) but not with red blood cell size or iron indices. Hyperviscosity symptoms were independent of iron indices but directly correlated with increased Hct-adjusted viscosity (r = 0.41, p = 0.01). Exercise capacity did not differ in iron-deficient patients. However, peak oxygen consumption was higher in those with Hct > or = 65% (12.6 +/- 3.4 ml/kg/m2 vs. 9.8 +/- 2.6 ml/kg/m2, mean +/- SD, p = 0.036) despite higher whole blood viscosity in these same individuals (p < 0.01 for all shear rates).
CONCLUSIONS: Iron deficiency is common in cyanotic adults but does not alter viscosity. Hyperviscosity symptoms are associated with a higher Hct-adjusted viscosity independent of cell size or iron stores. Higher Hct is associated with better exercise capacity. Further work to understand the origin of hyperviscosity symptoms is warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16843187     DOI: 10.1016/j.jacc.2006.03.040

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

Review 1.  The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1.

Authors:  Grazia Maria Virzì; Anna Clementi; Alessandra Brocca; Massimo de Cal; Giorgio Vescovo; Antonio Granata; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2014-05-14       Impact factor: 2.041

Review 2.  Congenital heart defects in adulthood.

Authors:  Gerhard-Paul Diller; Günter Breithardt; Helmut Baumgartner
Journal:  Dtsch Arztebl Int       Date:  2011-07-01       Impact factor: 5.594

3.  Adult patients with Eisenmenger syndrome report flying safely on commercial airlines.

Authors:  Craig S Broberg; Anselm Uebing; Linda Cuomo; Swee Lay Thein; Michael G Papadopoulos; Michael A Gatzoulis
Journal:  Heart       Date:  2006-12-12       Impact factor: 5.994

Review 4.  Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.

Authors:  Nazzareno Galie; Alessandra Manes; Massimiliano Palazzini; Luca Negro; Alessandro Marinelli; Simona Gambetti; Elisabetta Mariucci; Andrea Donti; Angelo Branzi; Fernando M Picchio
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease.

Authors:  Nattaphorn Hongsawong; Prapimdaw Khamdee; Suchaya Silvilairat; Wattana Chartapisak
Journal:  Pediatr Nephrol       Date:  2017-10-02       Impact factor: 3.714

6.  Numerical simulation of spatiotemporal red blood cell aggregation under sinusoidal pulsatile flow.

Authors:  Cheong-Ah Lee; Dong-Guk Paeng
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

7.  The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects.

Authors:  Erwin Oechslin; Siegrun Mebus; Ingram Schulze-Neick; Koichiro Niwa; Pedro T Trindade; Andreas Eicken; Alfred Hager; Irene Lang; John Hess; Harald Kaemmerer
Journal:  Curr Cardiol Rev       Date:  2010-11

Review 8.  Atrial septal defects and pulmonary arterial hypertension.

Authors:  Heba Nashat; Claudia Montanaro; Wei Li; Aleksander Kempny; Stephen J Wort; Konstantinos Dimopoulos; Michael A Gatzoulis; Sonya V Babu-Narayan
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

9.  Myocardial fibrosis in Eisenmenger syndrome: a descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival.

Authors:  Craig S Broberg; Sanjay K Prasad; Chad Carr; Sonya V Babu-Narayan; Konstantinos Dimopoulos; Michael A Gatzoulis
Journal:  J Cardiovasc Magn Reson       Date:  2014-05-14       Impact factor: 5.364

10.  Short-Term Impact of Iron Deficiency in Different Subsets of Patients with Precapillary Pulmonary Hypertension from an Eastern European Pulmonary Hypertension Referral Center.

Authors:  Ioan Tilea; Dorina Nastasia Petra; Razvan Constantin Serban; Manuela Rozalia Gabor; Mariana Cornelia Tilinca; Leonard Azamfirei; Andreea Varga
Journal:  Int J Gen Med       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.